Core Insights - Scatec's subsidiary Release has signed new lease agreements for 64 MW of solar power and 10 MWh of battery storage in Liberia and Sierra Leone, enhancing its renewable energy footprint in Sub-Saharan Africa [1][4] Group 1: Project Details - The lease agreements include a 15-year contract with Liberia Electricity Corporation for a 24 MW solar plant and a 10 MWh battery energy storage system in Duazon, near Monrovia [4] - In Sierra Leone, Release has secured a 40 MW solar project through a lease agreement with the national utility EGTC and the Ministry of Energy [4] - These projects will utilize a new solar panel mounting structure developed by Release's engineering team in South Africa, marking a significant milestone for the company [5] Group 2: Financial Support and Strategy - Release is supported by a USD 100 million loan and a USD 65 million guarantee facility from the World Bank's IFC, established in 2023, which helps mitigate financial risks for clients [3] - The partnership with the World Bank enables Release to provide affordable, clean power to African utilities, facilitating the adoption of renewable energy [3] Group 3: Company Background - Scatec, the majority owner of Release, is a leading renewable energy solutions provider with 6.2 GW of capacity in operation and under construction across five continents [6] - Release aims to overcome financial and technical barriers to solar energy adoption through flexible leasing agreements for pre-assembled solar PV and battery equipment [7]

Core Insights - Quadient has been awarded the IDC 2025 SaaS Subscription Management Customer Satisfaction Award for Accounts Receivable, indicating its strong position in the accounts receivable application market [1][4] - The recognition reflects Quadient's commitment to enhancing finance teams' efficiency through human-centric automation, providing a unified view of credit, collections, and cash application processes [2][3] Company Overview - Quadient is a global automation platform that facilitates secure and sustainable business connections, supporting digital transformation and operational efficiency for businesses of all sizes [6] - The company is listed on Euronext Paris and is part of the CAC Mid & Small and EnterNext Tech 40 indices, making its shares eligible for PEA-PME investing [6] Product Features - Quadient Accounts Receivable (AR) offers finance leaders instant visibility into outstanding balances, overdue invoices, and collection statuses through an intuitive dashboard, reducing manual effort and streamlining cash flow management [2][3] - The platform utilizes AI and machine learning to forecast cash flow with high accuracy, achieving prediction accuracy rates of up to 94% based on payment history and customer behavior [3] Customer Feedback - A healthcare staffing leader in the U.S. highlighted the transformative impact of Quadient's AR reporting capabilities, enabling better strategic decision-making and efficient processes [4] - The IDC SaaS Path Survey indicates that over half of the surveyed organizations expect to increase their SaaS AR spending in the next 12 months, showcasing a growing demand for intelligent financial automation [4]

Core Points - The General Meeting of Shareholders (GM) of AB "Ignitis grupė" is convened to elect a new Supervisory Board following a proposal from the Ministry of Finance of Lithuania [1][2] - The GM is scheduled for 24 October 2025, at 9:00 AM (Vilnius time), with registration starting at 8:00 AM [3][4] - The Ministry of Finance has completed background checks on two independent candidates for the Supervisory Board, proposing Jutta Maria Hildegard Dissen and Judith Buss [2][3] Summary by Sections General Meeting Details - The GM will elect seven out of nine members of the Supervisory Board due to incomplete background checks on two independent candidates as of 3 October 2025 [2] - The updated agenda includes the election of the Supervisory Board for a new term, with specific candidates listed [3][4] Candidates for Supervisory Board - The proposed candidates for the Supervisory Board include: 1. Alfonso Maximiliano Faubel Frauendorff 2. Aušra Vičkačkienė 3. Ingrida Muckutė 4. Lina Liubauskaitė 5. Lorraine Mary Wrafter 6. Sian Lloyd Rees 7. Timothy Guy Brooks 8. Jutta Maria Hildegard Dissen (energy transformation and flexibility technologies) 9. Judith Buss (finance and investment) [3][4]

AS Tallink Grupp will introduce the results of the third quarter of 2025 in an investor webinar. All shareholders and other stakeholders are invited to join the webinar, scheduled to take place on 23 October 2025 at 12:00 (EEST). The webinar will be held in English. The financial results will be presented by Margus Schults, the Member of the Management Board . We kindly ask participants to provide their questions before the webinar, latest by 11:00 am on 23 October 2025, by e-mail to: investor@tallink.ee. D ...

Aspo Plc Press Release 16 October 2025 at 9.00 am EEST Aspo has set science-based emission reduction targets – now approved by SBTi International Science Based Targets initiative (SBTi) has approved Aspo's near-term emission reduction targets. The targets are in line with the latest climate science to limit global warming to 1.5 degrees. Aspo's climate targets cover ESL Shipping and Telko. Aspo commits to decrease its direct greenhouse gas emissions (scope 1 and 2) with 42% by 2030. This will be achieved th ...

Core Insights - Cornish Metals Inc. has filed a technical report for its South Crofty tin project, which is fully permitted and located in Cornwall, UK [1][5] - The updated Preliminary Economic Assessment (PEA) indicates strong project economics, including a £180 million after-tax NPV at a tin price of US$33,900 per tonne and a 20% IRR [4][2] - The project is positioned as a low-cost, high-grade tin operation with strong ESG credentials, aiming for an average annual production of approximately 4,700 tonnes of tin [4][9] Project Economics - After-tax NPV of £180 million and pre-tax NPV of £237 million at a tin price of US$33,900 per tonne [4] - Project IRR of 20% after-tax and 23% pre-tax [4] - Capital payback period of 3.3 years post-production start [4] - Cumulative after-tax cash flow projected at approximately £558 million from production start [4] Production and Cost Metrics - Average annual after-tax cash flow of approximately £57 million in years two through six [4] - Average annual EBITDA of £70 million with a 62% EBITDA margin during the same period [4] - Average All-In Sustaining Cost (AISC) of approximately US$13,420 per tonne for years two through six, positioning South Crofty in the lowest quartile of the cost curve [4] Exploration Potential - Near mine exploration target indicates potential additional mineralization of 6 to 13 million tonnes at a tin grade of 0.5% to 1.8% [4] - The company has a resource drilling program planned to commence with underground development [4] Community and Regulatory Support - The project has strong support from local communities and government, with existing mine infrastructure and mining permission valid until 2071 [8][9] - The project is positioned to be the only primary tin producer in Europe or North America, contributing to the critical mineral supply chain [9]

Core Viewpoint - Viridien is set to announce its third quarter 2025 financial results on October 30, 2025, after market close, indicating a significant upcoming event for stakeholders [1]. Company Overview - Viridien is an advanced technology, digital, and Earth data company focused on sustainable solutions for complex challenges in natural resources, digital, energy transition, and infrastructure [3]. - The company employs approximately 3,200 people globally and is listed on Euronext Paris SA under the ticker VIRI [3]. Conference Call Details - Participants must register for the conference call to receive a dial-in number and PIN code, with options to join via live webcast [2]. - A replay of the conference call will be available for 12 months on the company's website [2]. - The press release and presentation will be accessible on the company's website at 5:45 PM (CET) on the announcement day, followed by an English-language conference call at 6:00 PM (CET) [5].

Core Points - Sampo plc has initiated a share buyback program with a maximum limit of EUR 200 million, which commenced on 7 August 2025 [1][2] - On 15 October 2025, Sampo plc acquired a total of 311,757 A shares at an average price of EUR 9.87 per share [1] - Following these transactions, Sampo plc now holds a total of 16,679,957 A shares, representing 0.62% of the total shares outstanding [2] Summary by Category Share Buyback Program - The share buyback program was announced on 6 August 2025 and is in compliance with the Market Abuse Regulation (EU) 596/2014 [1] - The program is based on the authorization granted by Sampo's Annual General Meeting on 23 April 2025 [1] Transaction Details - The daily buyback volume on 15 October 2025 included: - 3,263 shares at EUR 9.86 on AQEU - 114,861 shares at EUR 9.87 on CEUX - 37,716 shares at EUR 9.88 on TQEX - 155,917 shares at EUR 9.87 on XHEL [1] Ownership Post-Transactions - After the disclosed transactions, Sampo plc's total ownership of A shares is 16,679,957, which constitutes 0.62% of the total shares [2]

Core Viewpoint - Bavarian Nordic's Board of Directors maintains its recommendation for shareholders to accept the takeover offer from Innosera ApS, citing the offer as fair and attractive based on the company's fundamental value and historical share price levels [2][3]. Offer Details - The takeover offer is for all issued and outstanding shares of Bavarian Nordic, excluding treasury shares, made by Innosera ApS, which is controlled by Nordic Capital Fund XI and Permira Beteiligungsberatung GmbH [1]. - The offer period has been extended, and the offer price has been increased, prompting the Board to reiterate its recommendation [2][3]. Company Background - Bavarian Nordic is a global vaccine company focused on improving health through innovative vaccines, including mpox and smallpox vaccines, and has a strong portfolio of travel vaccines [7].

Core Insights - Novartis announced positive final results from the Phase III APPLAUSE-IgAN study, demonstrating that Fabhalta (iptacopan) significantly slows the progression of IgA nephropathy (IgAN) compared to placebo, as measured by the annualized total slope of estimated glomerular filtration rate (eGFR) decline over two years [1][8]. Company Developments - Novartis plans to use the positive APPLAUSE-IgAN data to support submissions for Fabhalta in 2026, alongside advancing its multi-asset IgAN portfolio, which includes Vanrafia (atrasentan) and the investigational compound zigakibart [2][3]. - Fabhalta has received multiple regulatory approvals, including FDA and European Commission approvals for treating adults with paroxysmal nocturnal hemoglobinuria (PNH) and accelerated approval for reducing proteinuria in adults with IgAN at risk of rapid disease progression [6][8]. Industry Context - IgAN is a progressive autoimmune kidney disease with approximately 25 new diagnoses per million people globally each year, leading to significant health challenges, including a high risk of kidney failure [3][4]. - The need for targeted therapies is underscored by the limitations of supportive care, which often fails to slow disease progression [3][12]. - Novartis is committed to addressing unmet needs in kidney health, focusing on innovative treatments that target the underlying causes of kidney diseases [12][13].